Business division sale boosts Novartis India profit to Rs.103 crore

Chennai, Nov 5 (IANS) Boosted by the sale of its over-the-counter division pharmaceutical player, Novartis India Ltd on Thursday said it closed the second quarter with a net profit of Rs.103.4 crore.

In a regulatory filing with BSE, the company said it had posted a net profit of Rs.103.4 crore for the quarter ended September 30, 2015 up from around Rs.14 crore for the quarter ended September 30, 2014.

The company’s total income for the period under review stood at Rs.224.43 crore down from around Rs.234.79 crore earned for the quarter ended September 30, 2014.

According to Novartis India, the company has received Rs.109.73 crore the sale consideration from GlaxoSmithKline Consumer Private Ltd and the same has been accounted in the books.

On the other hand the company has not accounted in in its books the Rs.86.7 crore sale consideration of its animal healthcare division to Elanco India – an Eli Lilly affiliate – as the deal is subject to regulatory approvals.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here